KOBAYASHI PHARM (KOY MU) stock market data APIs
€30.0099
0(0%)
as of July 7, 2025
Try our APIs with
free plan!
KOBAYASHI PHARM Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for KOY.MU.
Prev. Close
30.0099
Open
30.0099
High
30.0099
Low
30.0099
52 wk Range
29.5521-37.2871
Market Cap
5 563 M
Dividends (Yield)
0.8538
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get KOBAYASHI PHARM data using free add-ons & libraries
Get KOBAYASHI PHARM Fundamental Data
KOBAYASHI PHARM Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
KOBAYASHI PHARM News
New
Voting Cards Reveal that Over 50% of Shareholders Excluding the Founding Family and Related Parties Voted For Oasis’s EGM Proposals and Against Mr. Akihiro Kobayashi’s Renomination at the AGM
Details of the founding family related partiesApproval rates for proposals at the extraordinary general meeting of shareholdersApproval rates for Agenda 1 at the annual general meeting of shareholders...
Oasis Files Shareholder Derivative Lawsuit Against Kobayashi Pharmaceutical Directors
(Securities Code: 4967 JT) *On April 3, 2025, Oasis filed a shareholder derivative lawsuit with the Osaka District Court against the Directors of Kobayashi Pharmaceutical *The lawsuit is related to ...
Oasis Urges All Shareholders to Vote AGAINST the Appointment of Mr. Akihiro Kobayashi, Mr. Katae, Mr. Ohta and Mr. Takahashi as Directors at the Kobayashi Pharma AGM
(Securities Code: 4967 JT) * Oasis urges all shareholders to vote AGAINST the appointment of Mr. Akihiro Kobayashi, Mr. Katae, Mr. Ohta, and Mr. Takahashi as directors at the upcoming Kobayashi Pharm...
Oasis Secures Proxy Advisors' Support for Proposals that Address Serious Governance Concerns at Upcoming Kobayashi Pharma EGM
(Securities Code: 4967 JT) * Oasis nominated independent investigator to lead investigation into recent Beni-Koji scandal *Oasis nominated three highly qualified, independent, diverse director candi...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
